+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe Coronary Artery Bypass Graft Market Size, Share & Industry Trends Analysis Report By Procedure, By Method (Off-pump, On-pump, and Minimally Invasive Direct), By End-use (Hospitals, Cardiology Centers), By Country and Growth Forecast, 2023 - 2029

  • PDF Icon

    Report

  • 99 Pages
  • May 2023
  • Region: Europe
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5833827
The Europe Coronary Artery Bypass Graft Market should witness market growth of 8.6% CAGR during the forecast period (2023-2029).

Technological advancements in cardiac surgery methods are anticipated to enhance the market's revenue growth. Recent advancements in surgical techniques and medical technology have increased CABG operations' effectiveness and minimal invasiveness. Robotic-assisted surgical tools, for instance, are employed increasingly commonly because they allow for more precise and minimally invasive treatments.

Increased demand for minimally invasive procedures drives the market's revenue growth. Because they need less downtime and have fewer incisions, less invasive CABG treatments are becoming more popular among patients. The market's anticipated revenue growth will be fueled by the growing popularity of hybrid treatments that combine CABG surgery with Percutaneous Coronary Intervention (PCI).

The number of deaths from cardiovascular disease exceeds 1.8 million in the European Union (EU) and 3.9 million in Europe per year. Additionally, CVD is responsible for 37% of all fatalities in the EU. Compared to Southern, Northern, and Western Europe, Central & Eastern Europe has higher mortality rates from ischemic heart disease (IHD) and stroke. Eighty-five million people are estimated to have CVD in Europe, with 49 million living in the EU. the European region's participants in the market have excellent growth potential.

The Germany market dominated the Europe Coronary Artery Bypass Graft Market by Country in 2022 and would continue to be a dominant market till 2029; thereby, achieving a market value of $1,320.2 million by 2029. The UK market is exhibiting a CAGR of 7.6% during (2023-2029). Additionally, The France market should witness a CAGR of 9.4% during (2023-2029).

Based on Procedure, the market is segmented into Single CABG Surgery, Double CABG Surgery, Triple CABG Surgery, and Quadruple CABG Surgery. Based on Method, the market is segmented into Off-pump, On-pump, and Minimally Invasive Direct. Based on End-use, the market is segmented into Hospitals, Cardiology Centers, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Terumo Corporation, Karl Storz SE & Co. KG, Edwards Lifesciences Corporation, Johnson & Johnson (Ethicon, Inc.), Boston Scientific Corporation, Stryker Corporation, LivaNova PLC, Genesee BioMedical, Inc., and Vitalitec International Medizintechnik GmbH (Peters Surgical)

Scope of the Study

By Procedure

  • Single CABG Surgery
  • Double CABG Surgery
  • Triple CABG Surgery
  • Quadruple CABG Surgery

By Method

  • Off-pump
  • On-pump
  • Minimally Invasive Direct

By End-use

  • Hospitals
  • Cardiology Centers
  • Others

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

  • Medtronic PLC
  • Terumo Corporation
  • Karl Storz SE & Co. KG
  • Edwards Lifesciences Corporation
  • Johnson & Johnson (Ethicon, Inc.)
  • Boston Scientific Corporation
  • Stryker Corporation
  • LivaNova PLC
  • Genesee BioMedical, Inc.
  • Vitalitec International Medizintechnik GmbH (Peters Surgical)

Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Coronary Artery Bypass Graft Market, by Procedure
1.4.2 Europe Coronary Artery Bypass Graft Market, by Method
1.4.3 Europe Coronary Artery Bypass Graft Market, by End-use
1.4.4 Europe Coronary Artery Bypass Graft Market, by Country
1.5 Research Methodology
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Recent Strategies Deployed in Coronary Artery Bypass Graft Market
Chapter 4. Europe Coronary Artery Bypass Graft Market by Procedure
4.1 Europe Single CABG Surgery Market by Country
4.2 Europe Double CABG Surgery Market by Country
4.3 Europe Triple CABG Surgery Market by Country
4.4 Europe Quadruple CABG Surgery Market by Country
Chapter 5. Europe Coronary Artery Bypass Graft Market by Method
5.1 Europe Off-pump Market by Country
5.2 Europe On-pump Market by Country
5.3 Europe Minimally Invasive Direct Market by Country
Chapter 6. Europe Coronary Artery Bypass Graft Market by End-use
6.1 Europe Hospitals Market by Country
6.2 Europe Cardiology Centers Market by Country
6.3 Europe Others Market by Country
Chapter 7. Europe Coronary Artery Bypass Graft Market by Country
7.1 Germany Coronary Artery Bypass Graft Market
7.1.1 Germany Coronary Artery Bypass Graft Market by Procedure
7.1.2 Germany Coronary Artery Bypass Graft Market by Method
7.1.3 Germany Coronary Artery Bypass Graft Market by End-use
7.2 UK Coronary Artery Bypass Graft Market
7.2.1 UK Coronary Artery Bypass Graft Market by Procedure
7.2.2 UK Coronary Artery Bypass Graft Market by Method
7.2.3 UK Coronary Artery Bypass Graft Market by End-use
7.3 France Coronary Artery Bypass Graft Market
7.3.1 France Coronary Artery Bypass Graft Market by Procedure
7.3.2 France Coronary Artery Bypass Graft Market by Method
7.3.3 France Coronary Artery Bypass Graft Market by End-use
7.4 Russia Coronary Artery Bypass Graft Market
7.4.1 Russia Coronary Artery Bypass Graft Market by Procedure
7.4.2 Russia Coronary Artery Bypass Graft Market by Method
7.4.3 Russia Coronary Artery Bypass Graft Market by End-use
7.5 Spain Coronary Artery Bypass Graft Market
7.5.1 Spain Coronary Artery Bypass Graft Market by Procedure
7.5.2 Spain Coronary Artery Bypass Graft Market by Method
7.5.3 Spain Coronary Artery Bypass Graft Market by End-use
7.6 Italy Coronary Artery Bypass Graft Market
7.6.1 Italy Coronary Artery Bypass Graft Market by Procedure
7.6.2 Italy Coronary Artery Bypass Graft Market by Method
7.6.3 Italy Coronary Artery Bypass Graft Market by End-use
7.7 Rest of Europe Coronary Artery Bypass Graft Market
7.7.1 Rest of Europe Coronary Artery Bypass Graft Market by Procedure
7.7.2 Rest of Europe Coronary Artery Bypass Graft Market by Method
7.7.3 Rest of Europe Coronary Artery Bypass Graft Market by End-use
Chapter 8. Company Profiles
8.1 Medtronic PLC
8.1.1 Company overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent Strategies and Developments
8.1.5.1 Partnerships, Collaborations, and Agreements
8.1.5.2 Acquisition and Mergers
8.1.6 SWOT Analysis
8.2 Boston Scientific Corporation
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent Strategies and Developments
8.2.5.1 Acquisition and Mergers
8.2.5.2 Geographical Expansions
8.2.6 SWOT Analysis
8.3 Johnson & Johnson (Ethicon, Inc.)
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental &Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 SWOT Analysis
8.4 Terumo Corporation
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Regional Analysis
8.4.5 Recent Strategies and Developments
8.4.5.1 Partnerships, Collaborations, and Agreements
8.4.5.2 Acquisition and Mergers
8.4.5.3 Geographical Expansions
8.5 LivaNova PLC
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent Strategies and Developments
8.5.5.1 Product Launches and Product Expansions
8.6 Stryker Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent Strategies and Developments
8.6.5.1 Geographical Expansions
8.7 Edwards Lifesciences Corporation
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expenses
8.8 Vitalitec International Medizintechnik GmbH (Peters Surgical)
8.8.1 Company Overview
8.9 Genesee BioMedical, Inc.
8.9.1 Company Overview
8.10. Karl Storz SE & Co. KG
8.10.1 Company Overview

Companies Mentioned

  • Medtronic PLC
  • Terumo Corporation
  • Karl Storz SE & Co. KG
  • Edwards Lifesciences Corporation
  • Johnson & Johnson (Ethicon, Inc.)
  • Boston Scientific Corporation
  • Stryker Corporation
  • LivaNova PLC
  • Genesee BioMedical, Inc.
  • Vitalitec International Medizintechnik GmbH (Peters Surgical)

Methodology

Loading
LOADING...